UOB Asset Management anticipates a greater focus on Asian markets in 3Q 2025
SINGAPORE, June 24, 2025 /PRNewswire/ -- In its 3Q 2025 Quarterly Investment Strategy to be published this week, UOB Asset Management (UOBAM) highlights the almost equal probability of three US economic scenarios: a US recession, continued growth,...
England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy
First non-immunosuppressive dual-action therapy recommended by NICE for eligible patients with IgA nephropathy, a leading cause of kidney failure 1-3 NICE's recommendation is based on clinically meaningful results from the phase-III PROTECT trial 4...